Lite Strategy, Inc. (LITS)
NCM · Healthcare · Biotechnology
$0.74
+0.00%
Closing price as of 2026-06-12 · Source: TEK2day Finance
Key Metrics
Market Cap
$25.2M
Shares Outstanding
34.0M
Exchange
NCM
Currency
USD
About Lite Strategy, Inc.
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.
Quarterly Financials
| Metric | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -2.9M | -3.1M | -3.4M | -2.8M |
| Net Income | -2.7M | -3.6M | -30.8M | -23.7M |
| Diluted EPS | $nan | $-0.12 | $-0.82 | $-0.66 |
Annual Financials
| Metric | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 |
|---|---|---|---|---|
| Revenue | 40.7M | 48.8M | 65.3M | 0.00 |
| Gross Profit | 40.7M | |||
| Operating Income | -75.5M | -36.8M | 25.4M | -17.5M |
| Net Income | -54.5M | -31.8M | 17.8M | -15.9M |
| Diluted EPS | $-9.99 | $-4.78 | $2.67 | $-2.39 |